About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
$VERU insiders have traded $VERU stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales. Here’s a ...
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
Doctors say drugs that improve muscle mass could benefit older or infirm people at greater risk of falls and fractures ...
Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.
Regeneron (NASDAQ: REGN) is testing its drug, trevogrumab, along with Wegovy and another treatment, garetosmab, in a ...
In another example of the volatility facing developers of obesity drugs, Veru saw its share price cut nearly in half – despite reporting ostensibly positive data for a drug candidate.
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
The U.S. stock market recently experienced a sharp decline after two days of record highs for the S&P 500, with major indices like the Dow Jones and Nasdaq also seeing significant drops. For investors ...
After hours: 7:56:49 p.m. EST Loading Chart for MNMD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results